Literature DB >> 508510

Variability of plasma catecholamine levels: age, duration of posture and time of day.

N Saar, R D Gordon.   

Abstract

1. In order to define factors which influence plasma catecholamine levels, and which might be controlled in the interests of reproducability and comparability, plasma noradrenaline plus adrenaline (NA + A) was measured repeatedly in normal subjects by a double isotope technique. 2. Age and posture were important determinants for plasma NA + A levels, whereas time of day was less important. 3. Levels were higher in old men aged 70--92 years than in young men aged 19--28 years, measured after 30 min or 9 h (overnight) recumbency, or after 5 min standing. 4. Duration of recumbency and of upright posture were both important. Recumbent levels were lower after 9 h (overnight) than after 30 min (mid-morning). Upright posture caused an increase in levels within 2 min. Levels peaked between 5 and 20 min, were lower after 12 h than after 20 min, but upright levels were always higher than levels after 9 h recumbency. 5. During continuous recumbency, levels were lowest at 24.00 h, and increased thereafter. During a second hospitalisation, levels at 09.00 h were again higher than levels at 06.00 h after overnight recumbency. 6. Variability of levels obtained by repeated sampling was lower while sitting, during a normal upright day, than after 30 min recumbency. Upright legels may be a better index of cardiovascular sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 508510      PMCID: PMC1429847          DOI: 10.1111/j.1365-2125.1979.tb04718.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

1.  A map of blood and urinary changes related to circadian variations in adrenal cortical function in normal subjects.

Authors:  F C BARTTER; C S DELEA
Journal:  Ann N Y Acad Sci       Date:  1962-10-30       Impact factor: 5.691

2.  Effect of cold pressor stimulation on plasma norepinephrine, dopamine-beta-hydroxylase, and renin activity.

Authors:  N Winer; C Carter
Journal:  Life Sci       Date:  1977-03-01       Impact factor: 5.037

Review 3.  Catecholamines and hypertension.

Authors:  J Axelrod
Journal:  Clin Sci Mol Med Suppl       Date:  1976-12

4.  Lack of correlation between age and circulating catecholamines in hypertensive patients.

Authors:  J De Champlain; D Cousineau
Journal:  N Engl J Med       Date:  1977-09-22       Impact factor: 91.245

5.  Simultaneous single isotope radioenzymatic assay of plasma norepinephrine, epinephrine and dopamine.

Authors:  J D Peuler; G A Johnson
Journal:  Life Sci       Date:  1977-09-01       Impact factor: 5.037

6.  Validity of plasma-catecholamine estimations.

Authors:  M Carruthers; N Conway; W Somerville; P Taggart; D Bates
Journal:  Lancet       Date:  1970-07-11       Impact factor: 79.321

7.  Measurement of norepinephrine and epinephrine in small volumes of human plasma by a single isotope derivative method: response to the upright posture.

Authors:  P E Cryer; J V Santiago; S Shah
Journal:  J Clin Endocrinol Metab       Date:  1974-12       Impact factor: 5.958

8.  Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects.

Authors:  C R Lake; M G Ziegler; M D Coleman; I J Kopin
Journal:  N Engl J Med       Date:  1977-01-27       Impact factor: 91.245

9.  The variability of arterial pressure.

Authors:  W A Littler; M J West; A J Honour; P Sleight
Journal:  Am Heart J       Date:  1978-02       Impact factor: 4.749

10.  Plasma catecholamines in diabetes. The syndromes of hypoadrenergic and hyperadrenergic postural hypotension.

Authors:  P E Cryer; A B Silverberg; J V Santiago; S D Shah
Journal:  Am J Med       Date:  1978-03       Impact factor: 4.965

View more
  6 in total

1.  Effect of indoramin, labetalol and alinidine on sympathetic function in normal man.

Authors:  D P Nicholls; J McNeill; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

Review 2.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

3.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

4.  Effect of beta-adrenergic receptor blockade with propranolol on the response of plasma catecholamines and renin activity to upright tilting in normal subjects.

Authors:  R Vandongen; L Davidson; L J Beilin; A E Barden
Journal:  Br J Clin Pharmacol       Date:  1981-09       Impact factor: 4.335

5.  Effects of size, time of day and sequence of meal ingestion on carbohydrate tolerance in normal subjects.

Authors:  F J Service; L D Hall; R E Westland; P C O'Brien; V L Go; M W Haymond; R A Rizza
Journal:  Diabetologia       Date:  1983-10       Impact factor: 10.122

6.  Neurally mediated syncope: Is it really an endothelial dysfunction?

Authors:  Bahar Dehghan; Mohammad Reza Sabri; Shaghayegh Haghjooy Javanmard; Ali Reza Ahmadi; Marjan Mansourian
Journal:  Anatol J Cardiol       Date:  2015-07-29       Impact factor: 1.596

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.